Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
RTW INVESTMENTS, LP | 10%+ Owner | 40 10TH AVENUE, FLOOR 7, NEW YORK | /s/ Roderick Wong, for RTW Investments, LP, By: Roderick Wong, M.D., Managing Partner | 2025-08-06 | 0001493215 |
WONG RODERICK | 10%+ Owner | 40 10TH AVENUE, FLOOR 7, NEW YORK | /s/ Roderick Wong, By: Roderick Wong, M.D. | 2025-08-06 | 0001493280 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OBIO | Pre-Funded Warrants (Right to Buy) | Purchase | $10M | +3.64M | $2.75 | 3.64M | Aug 4, 2025 | Common Stock | 3.64M | $0.00 | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, together with their Attribution Parties (as defined in the Pre-Funded Warrants), to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. |
F2 | Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein. |